Hsp90 inhibition sensitizes DLBCL cells to cisplatin.
Saved in:
| Title: | Hsp90 inhibition sensitizes DLBCL cells to cisplatin. |
|---|---|
| Authors: | Schmidt L; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Issa II; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Haraldsdóttir H; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark., Hald JL; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark., Schmitz A; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark., Due H; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark., Dybkær K; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark. k.dybkaer@rn.dk.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. k.dybkaer@rn.dk.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark. k.dybkaer@rn.dk. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Apr; Vol. 89 (4), pp. 431-440. Date of Electronic Publication: 2022 Feb 21. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35190872 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hsp90 inhibition sensitizes DLBCL cells to cisplatin. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schmidt+L%22">Schmidt L</searchLink>; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Issa+II%22">Issa II</searchLink>; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Haraldsdóttir+H%22">Haraldsdóttir H</searchLink>; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Hald+JL%22">Hald JL</searchLink>; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Schmitz+A%22">Schmitz A</searchLink>; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Due+H%22">Due H</searchLink>; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Dybkær+K%22">Dybkær K</searchLink>; Department of Hematology, Aalborg University Hospital, Søndre Skovvej 15, 9000, Aalborg, Denmark. k.dybkaer@rn.dk.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. k.dybkaer@rn.dk.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark. k.dybkaer@rn.dk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2022 Apr; Vol. 89 (4), pp. 431-440. <i>Date of Electronic Publication: </i>2022 Feb 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35190872 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-022-04407-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 431 Titles: – TitleFull: Hsp90 inhibition sensitizes DLBCL cells to cisplatin. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schmidt L – PersonEntity: Name: NameFull: Issa II – PersonEntity: Name: NameFull: Haraldsdóttir H – PersonEntity: Name: NameFull: Hald JL – PersonEntity: Name: NameFull: Schmitz A – PersonEntity: Name: NameFull: Due H – PersonEntity: Name: NameFull: Dybkær K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2022 Apr Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1432-0843 Numbering: – Type: volume Value: 89 – Type: issue Value: 4 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |